NEW YORK – Genestack will integrate curated transcriptomic data from Nebion into its recently introduced Omics Data Manager system, the companies announced today.
The partnership will give customers of Cambridge, UK-based Genestack access to curated and annotated public transcriptomic studies. Nebion, of Zurich, Switzerland, also will, for a fee, license custom compendia of transcriptomics studies for integration into Omics Data Manager.
"Researchers in the pharmaceutical and biotech industry increasingly complement the analysis of their internal data with selected publicly available omics data. However, finding the relevant studies, curating them, and integrating them into your analysis workflow is a major challenge," Nebion CEO Philip Zimmermann said in a statement. "We are excited to work with Genestack towards making high-quality and deeply curated public data instantly accessible to researchers for more effective target and biomarker discovery and validation."
The companies said that the integration will follow FAIR (findable, accessible, interoperable, and reusable) principles set out by the European Life-Sciences Infrastructure for Biological Information (ELIXIR).
"Problems accessing and integrating quality data from multiple sources are key barriers to the adoption of AI and machine learning by the pharmaceutical and biotech industry," said Genestack CEO Misha Kapushesky. "Today, by combining Genestack's data infrastructure expertise with Nebion's curation and processing abilities, we are a step closer to eliminating such barriers and empowering users through data FAIRification."